A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog

8Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An 8-year-old female Shih Tzu was presented with weight loss and vomiting. Alanine aminotransferase was high and abdominal radiographs revealed hepato- and splenomegaly. Mild anaemia, neutrophilia with left shift, eosinophilia, and thrombocytosis with dysplastic features of eosinophils and platelets, were detected. The animal was initially considered to have hepatitis and was treated accordingly, but clinical signs persisted. Histological examination of liver biopsy samples showed disruption of the hepatic lobule, with extensive infiltration by haemopoietic cells. Further investigation of the bone marrow suggested a diagnosis of myelodysplastic syndrome. The animal was treated with cytarabine ocfosfate, a prodrug of cytosine arabinoside, and appeared to recover.

Cite

CITATION STYLE

APA

Ide, K., Momoi, Y., Minegishi, M., Sekiguchi, M., Konno, K., & Iwasaki, T. (2003). A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog. Australian Veterinary Journal, 81(1–2), 47–49. https://doi.org/10.1016/S0888-7543(02)00009-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free